Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 22, 2023 Filed Dec 26, 2023 17:35 UTC SaleCommon Stock 2,722.007 $200.01 $544,420.45
Disclosure

SEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 2

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,830.521

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 - $200.07, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 17:35 UTC Exercise / conversionCommon Stock 2,906 $148.07 $430,291.42
Disclosure

SEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,552.528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 16:27 UTC
keller brettDirector
GrantCommon Stock 155 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-011169 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,874

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 16:27 UTC GrantCommon Stock 155 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-011170 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,876

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 16:27 UTC
Zavery AmitDirector
GrantCommon Stock 141 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-011172 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,300

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 16:27 UTC GrantCommon Stock 155 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-011171 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,335

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 08, 2023 Filed Dec 11, 2023 13:33 UTC
Matlin LauraCVP, Deputy GC and CCO
Exercise / conversionStock Option (Right to Buy) · Derivative 4,178 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-23-010924 · doc4.xml · derivative · entry 4

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,178 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2023 Filed Dec 11, 2023 13:33 UTC
Matlin LauraCVP, Deputy GC and CCO
SaleCommon Stock 3,664 $189.49 $694,295.39
Disclosure

SEC source: 0001225208-23-010924 · doc4.xml · nonDerivative · entry 3

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,480.696

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.4200 - $189.4996, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 08, 2023 Filed Dec 11, 2023 13:33 UTC
Matlin LauraCVP, Deputy GC and CCO
SaleCommon Stock 426 $189.49 $80,723.21
Disclosure

SEC source: 0001225208-23-010924 · doc4.xml · nonDerivative · entry 2

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,144.696

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.4200 - $189.4996, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 08, 2023 Filed Dec 11, 2023 13:33 UTC
Matlin LauraCVP, Deputy GC and CCO
Exercise / conversionCommon Stock 4,178 $93.88 $392,230.64
Disclosure

SEC source: 0001225208-23-010924 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,570.696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2023 Filed Dec 1, 2023 21:03 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $117.34 $0.00
Disclosure

SEC source: 0001225208-23-010602 · doc4.xml · derivative · entry 6

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,854

Underlying: Common Stock · 10,000 shares

Expires 2030-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 01, 2023 Filed Dec 1, 2023 21:03 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $117.34 $0.00
Disclosure

SEC source: 0001225208-23-010602 · doc4.xml · derivative · entry 5

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,854

Underlying: Common Stock · 10,000 shares

Expires 2030-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 01, 2023 Filed Dec 1, 2023 21:03 UTC SaleCommon Stock 9,065 $192.43 $1,744,396.99
Disclosure

SEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 4

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,646.528

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.56 - $193.61, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
December 01, 2023 Filed Dec 1, 2023 21:03 UTC SaleCommon Stock 9,026 $195.21 $1,761,975.39
Disclosure

SEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 3

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,711.528

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.00 - $195.60, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
December 01, 2023 Filed Dec 1, 2023 21:03 UTC Exercise / conversionCommon Stock 10,000 $117.34 $1,173,400.00
Disclosure

SEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 2

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,737.528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 01, 2023 Filed Dec 1, 2023 21:03 UTC Exercise / conversionCommon Stock 10,000 $117.34 $1,173,400.00
Disclosure

SEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,737.528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
November 10, 2023 Filed Nov 13, 2023 17:57 UTC
KALENKA ROBERT FCorporate Vice President
GiftCommon Stock 60 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010179 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,759.4097

F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person.

Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:54 UTC
Gumbs Keir DCVP and Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,151 $0.00 Strike: $144.84 $0.00
Disclosure

SEC source: 0001225208-23-010148 · doc4.xml · derivative · entry 3

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,456

Underlying: Common Stock · 4,151 shares

Expires 2032-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:54 UTC
Gumbs Keir DCVP and Chief Legal Officer
SaleCommon Stock 3,771 $176.61 $665,992.92
Disclosure

SEC source: 0001225208-23-010148 · doc4.xml · nonDerivative · entry 2

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,402.98

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.55 - $176.62, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:54 UTC
Gumbs Keir DCVP and Chief Legal Officer
Exercise / conversionCommon Stock 4,151 $144.84 $601,230.84
Disclosure

SEC source: 0001225208-23-010148 · doc4.xml · nonDerivative · entry 1

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,173.98

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010198 · doc4.xml · derivative · entry 3

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010198 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,567

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010199 · doc4.xml · derivative · entry 2

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010199 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,676

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC
keller brettDirector
GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010200 · doc4.xml · derivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC
keller brettDirector
GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010200 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,719

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 15:20 UTC GrantStock Option (Right to Buy) · Derivative 3,037 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010196 · doc4.xml · derivative · entry 2

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,037

Underlying: Common Stock · 3,037 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 15:20 UTC GrantCommon Stock 729 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010196 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,279

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010202 · doc4.xml · derivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010202 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,721

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC
Zavery AmitDirector
GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010204 · doc4.xml · derivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC
Zavery AmitDirector
GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010204 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,159

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010203 · doc4.xml · derivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010203 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,180

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010201 · doc4.xml · derivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010201 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,442.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantStock Option (Right to Buy) · Derivative 2,241 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-23-010197 · doc4.xml · derivative · entry 2

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,241

Underlying: Common Stock · 2,241 shares

Expires 2033-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 20:20 UTC GrantCommon Stock 538 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010197 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,595

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 08, 2023 Filed Nov 9, 2023 18:00 UTC SaleCommon Stock 20,614 $176.94 $3,647,480.33
Disclosure

SEC source: 0001225208-23-010124 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,737.528

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.93 - $178.03, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC GrantCommon Stock 83 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009419 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,029

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 09:05 UTC GrantCommon Stock 83 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009425 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,061

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009420 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,138

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC
keller brettDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009421 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,181

F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC
keller brettDirector
GrantCommon Stock 32 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009421 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,169

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 09:05 UTC GrantCommon Stock 120 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009417 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,550

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009423 · doc4.xml · nonDerivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,183

F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009423 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,182

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC
Zavery AmitDirector
GrantCommon Stock 10 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009426 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,621

F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC
Zavery AmitDirector
GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009426 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,611

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 13:05 UTC GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-009424 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,642

F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.